|
ÂåÀø³q¸ô«O°·¹«~NO.1-±M·~ÂåÀø°|©Ò³q¸ô¨ÑÀ³°Ó ¥xÆW»®¦Ó¥q¦³¤½¥q³d¥ô¾P°â §K¥I¶OqÁʱM½u:0800-000-084 °·±dDIY¤ÑµM£°©|¦n~²z©Ê®ø¶O,Áo©ú¿ï¾Ü! |
°ü¤k°·±dÂåÀø±M·~ºô §ó·s:2008¦~11¤ë7¤é ¤H®ð |
| ¤ÑµM¯]¨©¶t+ºû¥L©RD | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
ª©ÅvÁn©ú:¥»ºô¶¤º®eÄÝ¥xÆW»®¦Ó¥q¦³¤½¥q,¦P·~½Ð¦Û¨î,¥¼¸g±ÂÅv,¤Å«þ¨©©Î½Æ»s¨Ï¥Î.ªk«ßÅU°Ý:®e»P°ê»Úªk«ß¨Æ°È©Ò EMPROVE®¬O¼w°ê ¡@ ¡@ ¡@ ¯d¦í°©¥»¨Åé¦n! ¡@ ¡@
¡@ ¡@ EMPROVE ¡@ ¡@ ¡@ ¡@ ¼w°êÀq§J¤ÑµM¶t ¡@ ¡´EMPROVE²Å¦X¼Ú·ùPhEurÃĨå³W½d ¡´EMPROVE²Å¦X^°êBPÃĨå³W½d ¡´EMPROVE²Å¦X¬ü°êUSPÃĨå³W½d
¡@ ¡@ ºû«ù°©Àf°·±dªº¦n¹Ù¦ñ
¡@ ¡@ ¬¡©Ê¶tÂ÷¤l¤ñ¨Ò°ª¹F40%!¤HÅé§Q¥Î²v°ª~ ¡@ »â¥ý²K¥[400IU¨¬¶q¶§¥úºû¥L©RD3 ¡@ ¡@ ¡@ ¡´¼w°ê100%¤ÑµM¶t·½Calcium Carbonate. ¡´²K¥[ºû¥L©RD3,¥i«P¶i¸z¹D§l¦¬¶t½è. ¡´§l¦¬§¹¥þ,¸û¤£·|¼W¥[¨Åét¾á. ¡´§t¬¡©Ê¶tÂ÷¤l¤ñ¨Ò³Ì°ª¹F40%.(¦p¤U¹Ï) ¡@
¬ü°êÃĨåUSP22 ¡@ ¡@ ¨C¿õ¦¨¥÷: ¨C¿õ§t¦³¼w°êEMPROVE¤ÑµM¶t1340mg(¬ù§t¦³¶tÂ÷¤l500mg)²K¥[¨¬¶qºû¥L©RD3 400IU ¡@ ¤@¯ë¥Î³~: ¶t: ºc¦¨¤ú¾¦»P°©Àfªº¥Dn¦¨¤À¡Cºû«ù¤ßŦ¡B¦Ù¦×¥¿±`¦¬ÁY¤Î¯«¸gªº·PÀ³©Ê¡C¬¡¤Æ¾®¦å酶¤¸ÂàÅܬ°¾®¦å酶¡AÀ°§U¦å²G¾®©T¡C ±±¨î²ÓMªº³q³z©Ê¡Cºû«ù°©Àf¤Î¤ú¾¦ªº°·±d¡Cºû¥Í¯ÀD3: À°§U©Î«P¶i¶t¡BÁCªº§l¦¬¤Î§Q¥Î¡CÀ°§U°©Àf¤Î¤ú¾¦ªº¥Íªøµo¨|¡C À°§Uºû«ù¦å¶tªº¥¿±`¿@«×¡Cºû«ù¯«¸g¡B¦Ù¦×¥Í²zªº¥¿±`¡CÀ°§U°©Àf¶t¤Æ(calcification)¡C ¹B°Ê¶q¤Ö©Î¤£³ßÅw¤á¥~¬¡°ÊªÌ¤×¨äÀ³¸Ó¸É¥R¡C ¡@ Ãö©ó¶tªº°g«ä:¸É¶t©ö¥Íµ²¥Û¡S ¥Ø«e³oºØ»¡ªk¤w³Q±À½¡A®Ú¾Ú³o¨Ç¦~ªº¬ã¨sµ²ªGµo²{¡GÁöµM¤j¦h¼ÆµÇµ²¥Û±wªÌªºµ²¥Û¦¨¥÷¤¤§t¦³¶t½è¡A¦ý¬O¤Þ°_µ²¥Ûªº¸o»íº×º¨Ã¤£¬O¡u¶¼¹¤¤¦Y¤F¤Ó¦hªº¶t½è¡v¡A¦Ó¬O¡u¤ô³Ü¤Ó¤Ö¤F¡I¡v·íµM¡A³y¦¨µ²¥Ûªºì¦]¨Ã¤£³æ¯Â¡A¡u¤ô³Üªº¤£°÷¡I¡v¥u¬Oì¦]¤§¤@¡A¦]¬°¤ô¥÷¤£¨¬¡A¨ÏµÇŦ©Ò§Î¦¨ªº§¿¶q¤£°÷¡AµLªk±N¥i¯à§Î¦¨µ²¥Ûªºª«½èµ}ÄÀ¡A¥HP³y¦¨¹L¹¡©Mª¬ºA¡A²£¥Íµ²´¹¦Ó§Î¦¨µ²¥Û¡A·í¶tÄá¨ú¤£¨¬¡A¦å²G¤¤¶tÂ÷¤l¿@«×¹L§C®É¡A°Æ¥Òª¬¸¢¯À·|¦Û°©Àf¤¤´£¨ú¶tÂ÷¤lÄÀ©ñ¦Ü¦å²G¤¤¡A¥H´£ª@¦å¶t¿@«×¡A³Q´£¨ú¥X¨Óªº¶tÂ÷¤l«D±`¤£Ã©w¡A®e©ö»P¦å²G¤¤ªº¯ó»Äµ²¦X,§Î¦¨¯ó»Ä¶t,¤~¬O³y¦¨µ²¥Ûªº¤¸¥û¡C¦pªG¶tÄá¨ú¾A·í¡A¶t½è·|¦b¸z¹D»P¯ó»Äµ²¦X,§Î¦¨¤£³Q·»¸Ñ¤]¤£³Q§l¦¬ªº¯ó»Ä¶t,¸g¥ÑÁT«K±Æ¥X,³o¼Ë¤Ï¦Ó¥i¥H´î¤Ö§¿²G¤¤ªº¯ó»Ä¡C ³Ì·sµoªí¦b°ê»Ú¤º¬ìÂå¾Ç»xArchives of Internal Medicine.ªº¤åÄm°lÂÜ96,245¦ì¦~ÄÖ27~ 44·³ªº¤k©Ê,µo²{¸É¥R¶t½è¨Ã¤£·|¼W¥[µÇŦµ²¥Ûªº¾÷²v:Higher Calcium Intake May Decrease Risk of Kidney Stones in Younger Women µ²¥Û³£¬O¶t½è·Sªºº×¡H ¡@ ±zª¾¹D¶Ü?¬Ã¯]¯»ªº¥Dn¦¨¤À´N¬O¶t! ¡@ ²K¥[¨¬¶qºû¥L©RD3 400IU,µ¹±z¦h¤@¼h«OÅ@! ³Ì·s¤åÄm³ø§i«ü¥X:¸É¥R¨¬¶qªººû¥L©RD3¨C¤Ñ800 IU°ê»Ú³æ¦ì,°·±d§ó¦³«O»Ù! ¡´Higher Vitamin D Intake May Reduce the Risk of Breast Cancer in Postmenopausal Women ¡´Vitamin D, calcium combo may cut exercise-related stress fractures ¡´Vitamin D-calcium combo provides long-term benefits for men¡´Calcium and vitamin D linked to cutting fractures ¡´Vitamin D bone benefits need added calcium, study ¡´Lack
of vitamin D linked to depression in elderly ¬ü°êFDA¦b2008¦~9¤ë¤½§i¦P·N¶t½è²K¥[ºû¥L©RD3¥i¥H§ó¥[À°§Uºû«ù°©Àfªº°·±d¡C FDA Allows Vitamin D to be Added to Calcium Osteoporosis Claims¡K The Food and Drug Administration (FDA) is amending its labeling regulation authorizing a health claim on the relationship between calcium and a reduced risk of osteoporosis to include vitamin D in claims made for calcium and vitamin D and osteoporosis. The change is effective January 1, 2010. The major amendment will permit products that bear a calcium and osteoporosis claim to also make reference to vitamin D content and its ability to benefit bone health. Other amendments in the published final rule include: elimination of the requirement to list sex, race, and age as specific risk factors for the development of osteoporosis; and no requirement for stating that osteoporosis risk is equally applicable to the general U.S. population. Identifying the mechanism by which calcium reduces the risk of osteoporosis is now optional, and requiring the claim to state that a total dietary intake greater than 200 percent of the recommended daily intake (2,000 milligrams of calcium) has no further benefit to bone health when the food contains 400 milligrams or more of calcium per reference amount customarily consumed or per total daily recommended supplement intake has been eliminated. The amended rule also makes references to physical activity optional rather than required. The entire regulation is available at http://edocket.access.gpo.gov/2008/E8-22730.htm. ¡@ «ØÄ³¹¥Îªk: 1.½Õ¸`¥Í²z¾÷¯à:¨C¤é¹¥Î1~2²É¡A¤£n»P³½ªo¤@°_¹¥Î¡A¦]¬°ªo»Ä©M¶tÂ÷¤l·|²£¥Í¨m¤Æ¤ÏÀ³¡A¥i¯à·|³y¦¨©Ô¨{¤l¡A¦Ó¥B®ÄªG·|¤j¥´§é¦©¡C 2.1-5·³¨àµ£¨C¤é¹¥Î1²É¡A¦h¹µL¯q¡A6·³¥H¤W«Äµ£¨C¤é¹¥Î1-2²É¡A¥i¿i¸H¹¥Î¡C
3.²£«e²£«á¤§Àç¾i¸Éµ¹:Ãh¥¥ªì´Á/¤¤´Á¨C¤é¹¥Î1²É¡CÃh¥¥«á´Á¨C¤é¹¥Î2²É¡C 4.¤¤¦~¥H¤W°ü¤k:¨C¤é¹¥Î1~2²É¡A°t¦X´¶Ã¹°Òµ·´Óª«»Û¿E¯À1~2²É¡A«O¾i¹B°Ê¾÷¯à¥i°t¦XÃö°·500¸²µå¿}®ò+³n°©¯À2~3²É¡C 5.¤¤¦~¥H¤W¨k¤h:¨C¤é¹¥Î1~2²É¡A«O¾i¹B°Ê¾÷¯à¥i°t¦XÃö°·500¸²µå¿}®ò+³n°©¯À2~3²É¡C 6.¦Ñ¦~±Ú¸s:«ØÄ³·f°tÅ餺Àô«O¯q¥Íµß¨C¤é¹¥Î1~2²É¡A¥i¥HÀ°§Uºû«ù®ø¤Æ¹D¾÷¯à¡A«P¶i¶t½èªº§l¦¬¡C ¡@ ª`·N¨Æ¶µ: 1.µÇ¥\¯à¤£¦nªº¤H¤£©y¿ï§tÁC»Ä¶tªº¶t¤ù¡A¥H§K³y¦¨µÇŦt¾á¡C¤j¦h¼Æ¤¤ªø´Á¹¥Î¶t¤ùªÌ¤£·|¤£¨}¤ÏÀ³¡A¦ý¦³µÇµ²¥Û¯f¥vªº¤H¡A¦b¹¥Î¤§«e¥²¶·½Ð±ÐÂå®vªº·N¨£¡C¨C¤é¹¥Î¶t¤ù¤Î°ª¶t¹«~ªº¤H¡A¤]n·í¤ß¶t½èÄá¨ú¤£n¹L¶q¡AY¨C¤é¶tÄá¨ú¶W¹L¤G¤d¤¦Ê²@§J´Nºâ¹L¶q¤F¡C 2.¶t¤ù¤£n»P¸²µå¿}Ói¦P®É¹¥Î¡A¦]¬°³Ì·sªº¬ã¨sÅã¥Ü:¶t¤ù»ÝnG»Ä¨Ó¤À¸Ñ¥X¶tÂ÷¤l¡A¦ý¬O¸²µå¿}ÓiÄÝÆP©Ê¡A·|¤¬¬Û¤zÂZ¡A´î¤Ö§l¦¬¶q¡A¸²µå¿}ÓiÀ³À\«e15¤ÀÄÁ¹¥Î¡A¶t¤ùÀ\«á¹¥Î¡C ¡@
¡@ ¡@ ´I§t¶t½èªº¹ª«¡G °Êª«©Ê¶t½è:¤p³½°®¡B§k¥J³½¡B½¼¦Ì¡B±a³½°©ªº³½ÅøÀY¡B¥ÍÄ®¡B°FÃþµ¥¡B¤û¥¤¡B¨Å¹T¡B»Ä¨Å¹T¡B±Æ°©¦×Ãþ¡B ´Óª«©Ê¶t½è:¨§»G¡B¤ôªG¡BÀu®æ¡B®ü±a¡Bµµµæ¡BÀY¾vµæ¡Bª÷°w¡B¤ì¦Õ¡Bºñ¸½µæ¡B¤ÎªÛ³Â½k½\Ãþµ¥³£§t¦³Â×´I¶t½è¥B¨ä¶t½è©ö³Q¤HÅé§l¦¬¡C ¥t¦³·Rº¸Äõ¬õĦ¶t-¤ÑµM¯]¨©¶t+D3-¸²µå¿}®ò³n°©¯À
¹q¸Üq³f±M½u:02-26336117/§K¥I¶OqÁʱM½u:0800-000-084
¶Ç¯u:02-26334066 /E-mail:customer@healthwomen.com.tw ¢xqÁÊ»¡©ú¢x ¤p¥]¸ËqÁʳæ
¢x¶q³c§åµo¢x¦^º¶¢x ¬ÛÃö²£«~³sµ²: ¡´®Â½Ã¨p±K°·±d½Ã¥Í: °ü²b±d¨Å»Äµß-¥iÄõ²ù¿@ÁY½¯¶V²ù-°ü²b²n¾®½¦-¬X±¡¾®½¦¡´´Óª«¶Pº¸»X:´¶Ã¹°Òµ·»Û¿E¯À-¸t¼ä²ù¶ÀÅé¯À-¤sÃÄºëµØ¡´¯·²À¤j§@¾Ô:¹¡¨¬の¤@µf¿ÄRÅÖªQ¤lªo-´N¬On§¹¬üCLA¦@³m¨È³Âªo-¤G¥NµÇ§Î¨§PHASE-2 -¯ù¤Áの¤@µfFASLIM-EGCG-ºÎ¬ü¤H ¬¡¤O¯·²ÀÐ`肽¥]-¥Ò殻¯À-ÃöÀªGHCA-®üĦºë-¥d¥§¥Å-ÂźñĦ-°à°s»Ã¥À-Å餺Àô«O¨Å±ìµß-²`®ü³½ªo-¤ë¨£¯ó-W¾í-°ªÅÖ¿õ-¬ü¹Ú¦¨¯u¡´Å餺¬üùÛ¨t:»²»Ã¯ÀQ-10-¥þ¼h«OÀãÁɵ¸¬ü±oCeramide-¬¡ÃC¯ÀHA-100-¸²µå¬óOPC-EGCG-ÀØ®üªQ-»È§ö-X¬õ¯À ¡´±j¨ºû¥L©R:LP-300½Õ¾ãÅé½è¯q¥Íµß- ¤G¥N¶W·L²É¸¶À¯À-¯ó¥»¦n¤ß±¡-¦n¯«µÎ¬¡GABA-X¬õ¯À+´ÄÃq-ÁxÆPB¸s-¨xºë-¸²µå¿}®ò³n°©¯À¡´ ¥´³yE¥@¥NÀu½èÄ_Ä_:¸»ÄB¸sÅK¾¯-DHA/AAª÷¥©´Óª«³½ªo-¤ÑµM¯]¨©¶t ¡´²£«e²£«á½Õ¾i:¦³¾÷¥ÍÁ¤¯À-ªk°ê§³®W«O¾iÁ÷¡´¤ÑµM-¦³¾÷-¯À¹:¤é¥»¦³¾÷¯Ç¨§¬õÄT-·Rº¸Äõ¦³¾÷¬õĦ¶t-¦³¾÷ÂźñĦÁ³±ÛĦ-¦³¾÷°ª¿@ÁY¤ë¨£¯ó ¡@ ¢x«O°·¹«~¿ïÁʯµÓD¢x¤p¥]¸ËqÁÊ¢x¶q³c§åµoqÁʬD¾Ô¥þ°ê³Ì§C»ù!¢xqÁÊ»¡©ú¢x®ü¥~¤Î´ä¿D¤j³°qÁÊ¢x ¡@ »´ÃPÅéÅç¥þ²y³»¦yÀç¾i¯À¶}µo¼t¬ì§ÞºëµØ! |
||||||||||||||||||||||||||